Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

Clinical trial NCT02878603 · COMPLETED

Trial details

NCT number: NCT02878603
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acquired Thrombotic Thrombocytopenic Purpura

Start date: 2016-10-06
Primary completion: 2020-10-23
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.